Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1996
12/19/1996WO1996040147A1 Use of debromohymenialdisine and related compounds for treating osteoarthritis
12/19/1996WO1996040146A1 Novel 5-cyclopropyl-1,4 benzodiazepine-2-ones
12/19/1996WO1996040145A1 Methods of combatting infectious diseases using dicationic bis-benzimidazoles
12/19/1996WO1996040144A1 Oral acyclovir delivery
12/19/1996WO1996040143A1 Imidazole compounds
12/19/1996WO1996040142A1 Heterocyclic ring-fused pyrimidine derivatives
12/19/1996WO1996040140A1 Inhibitors of rotamase enzyme activity
12/19/1996WO1996040139A1 Novel formulations for transdermal delivery of pergolide
12/19/1996WO1996040138A1 Chloroquine analogs and methods of preventing and treating plasmodial disease
12/19/1996WO1996040137A1 METHODS OF MODULATING NF-kB TRANSCRIPTION FACTOR
12/19/1996WO1996040136A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST
12/19/1996WO1996040135A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/19/1996WO1996040134A1 Calcium channel antagonists
12/19/1996WO1996040133A1 Optically pure (-) norcisapride for treating digestive tract disorders
12/19/1996WO1996040132A1 Method for inhibiting neoplastic disease in mammals
12/19/1996WO1996040131A1 Method for inhibiting neoplastic disease in mammals
12/19/1996WO1996040130A1 Methods of inducing bef-1 transcription factor
12/19/1996WO1996040128A2 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
12/19/1996WO1996040127A1 Nitroxides as protectors against oxidative stress
12/19/1996WO1996040126A1 1h-4(5)-substituted imidazole derivatives
12/19/1996WO1996040125A1 Anti-viral compounds
12/19/1996WO1996040124A1 Anti-viral compounds
12/19/1996WO1996040123A1 Antigen-processing cell-targeted conjugates
12/19/1996WO1996040122A1 Use of benzimidazoles for the manufacture of a medicament for the treatment of leukemia
12/19/1996WO1996040121A1 Antifungal agent
12/19/1996WO1996040120A1 Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
12/19/1996WO1996040119A1 Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
12/19/1996WO1996040117A1 Methods of treating microbial infections
12/19/1996WO1996040116A1 Indolinone compounds for the treatment of disease
12/19/1996WO1996040115A1 Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions
12/19/1996WO1996040114A1 Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor
12/19/1996WO1996040113A2 Phosphatase inhibitors
12/19/1996WO1996040112A1 Use of brefeldin a and derivatives thereof in the treatment of hyperplasia and related disorders
12/19/1996WO1996040110A1 Novel benzopyran compounds and methods for their use
12/19/1996WO1996040108A1 Multidentate metal complexes and methods of making and using thereof
12/19/1996WO1996040107A1 The use of n,n'-bis(mercaptoacetyl) hydrazine drivatives as anticataract agents
12/19/1996WO1996040106A2 Methods for controlling highly unsaturated fatty acid content in various tissues
12/19/1996WO1996040105A1 Use of gamma-hydroxybutyrate for the stimulation of sleep-related growth hormone secretion
12/19/1996WO1996040104A1 Hydroxyl ions as unique therapeutic agents and compounds that modulate ions, compounds
12/19/1996WO1996040103A1 Treatment of a trabecular meshwork whose cells are subject ot inhibition of cell division with non-steroidal anti-inflammatory drugs
12/19/1996WO1996040102A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
12/19/1996WO1996040101A1 Certain arylsulfonamido-substituted hydroxamic acids for the treatment of certain tumors
12/19/1996WO1996040100A1 ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS
12/19/1996WO1996040099A1 Method for regulating glucose metabolism
12/19/1996WO1996040098A2 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
12/19/1996WO1996040097A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
12/19/1996WO1996040096A1 INHIBITION OF CANCER CELL GROWTH, PROLIFERATION AND METASTASIS USING N,N'-DIBENZYL-α,φ-DIAMINOALKANES
12/19/1996WO1996040095A1 Method for treating multiple sclerosis
12/19/1996WO1996040094A1 Use of selegiline to treat hearing loss in mammals
12/19/1996WO1996040093A2 Bis phenol or phenozy compounds for immune modulation
12/19/1996WO1996040092A1 Pharmaceutically active carotenoids
12/19/1996WO1996040090A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
12/19/1996WO1996040088A1 Acyclovir derivatives for topical use
12/19/1996WO1996040086A2 Compositions and methods for topical administration of pharmaceutically active agents
12/19/1996WO1996040085A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
12/19/1996WO1996040084A1 Compositions and methods for use of pressure sensitive adhesive transdermal devices containing a bioadhesive humectant
12/19/1996WO1996040079A1 Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
12/19/1996WO1996040078A1 Delivery of drugs to the lower gi tract
12/19/1996WO1996040068A1 Methods and system for processing dispersible fine powders
12/19/1996WO1996040059A1 Dinucleotides useful for the treatment of lung disease
12/19/1996WO1996040058A2 Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir
12/19/1996WO1996040056A1 Polyether block copolymer micellar compositions for targeting biological agents
12/19/1996WO1996040055A2 Biological agent compositions
12/19/1996WO1996040054A2 Intraurethral pharmacotherapy of incontinence
12/19/1996WO1996040048A2 Novel uses for thyroid hormones or thyroid hormone-like compounds
12/19/1996WO1996040047A1 Alpha hydroxyacid esters for skin aging
12/19/1996WO1996040043A2 Neuroactive steroids of the androstane and pregnane series
12/19/1996WO1996040042A2 Stabilized steroid compositions
12/19/1996WO1996040040A2 Thrombin receptor homolog
12/19/1996WO1996040038A2 Treatment of anemia with procaine compositions
12/19/1996WO1996039996A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors
12/19/1996WO1996039978A1 Therapeutic use of acetazolamide for the treatment of brain edema
12/19/1996WO1996039869A1 Health food product
12/19/1996WO1996039838A1 Methods of inhibiting bacterial sialidase
12/19/1996WO1996039835A1 Method of solubilizing and encapsulating itraconazole
12/19/1996WO1996039833A1 Modulation of calcium channels
12/19/1996WO1996039832A1 Compounds and methods for promoting hair growth
12/19/1996WO1996039831A1 Prodrugs of pharmaceuticals with improved bioavailability
12/19/1996WO1996039829A1 New cryptophycins
12/19/1996WO1996039815A1 Psoralen-binding polymers
12/19/1996WO1996036222A3 Improved method for controlling ectoparasites
12/19/1996WO1996031237A3 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
12/19/1996WO1996029973A3 Compositions and methods for inhibiting thrombogenesis
12/19/1996CA2704354A1 Expression of lipoproteins
12/19/1996CA2451973A1 Method of increasing the solubility of tissue factor pathway inhibitor
12/19/1996CA2451970A1 Method to aid refolding of tissue factor pathway inhibitor
12/19/1996CA2451969A1 Method of purifying tissue factor pathway inhibitor
12/19/1996CA2450953A1 Method of solubilizing, purifying, and refolding protein
12/19/1996CA2450804A1 Method of solubilizing, purifying, and refolding protein
12/19/1996CA2450800A1 Method of solubilizing, purifying, and refolding protein
12/19/1996CA2450797A1 Method of solubilizing proteins containing two oppositely-charged domains
12/19/1996CA2450795A1 Method of refolding tissue factor pathway inhibitor
12/19/1996CA2352900A1 Small molecule inhibitors of rotamase enzyme activity
12/19/1996CA2247984A1 Orally active adenosine kinase inhibitors
12/19/1996CA2247983A1 Water-soluble adenosine kinase inhibitors
12/19/1996CA2236946A1 Polyether block copolymer micellar compositions for targeting biological agents
12/19/1996CA2224463A1 Ocular therapy in sjogren's syndrome using topically applied androgens or tgf-.beta.
12/19/1996CA2224230A1 Oral acyclovir delivery
12/19/1996CA2224227A1 Use of essential oils to increase bioavailability of oral pharmaceutical compounds
12/19/1996CA2224222A1 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
1 ... 6846 6847 6848 6849 6850 6851 6852 6853 6854 6855 6856 6857 6858 6859 6860 6861 6862 6863 6864 6865 6866 ... 7860